DUBLIN, March 7, 2018 /PRNewswire/ --
The "Global Medical Aesthetics Industry: Injectables, Energy-Based Devices, Cosmeceuticals, Cosmetic Surgery, Facial Aesthetics, Implants, Cosmetic Tourism. Market Analysis & Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
This analysis indicates that the current medical aesthetic industry is worth $53.3 billion for both service and product revenue.
Over the next five years a CAGR of 5.5% is expected and the market will hit $73.6 billion in 2022. Currently, invasive aesthetic procedures generate revenues of over $27.8 billion, annually.
The analysis indicate that by 2022, invasive aesthetic procedures will grow at a CAGR of 4.3%. Non-invasive procedures generate approximately $16.7 billion per annum and will grow at a CAGR of 4.5% over the coming five years. Cosmetic surgery products generated $8.8 billion in 2016 and have the potential to reach $15.3 billion in 2022.
Nonsurgical treatments lead the way across the globe and are broadly classified into three major categories: injectable products, energy based devices and active cosmetics. Injectable products include neurotoxins such as Botox and dermal fillers such as Restylane and they have the largest market share. These are followed by energy-based devices such as lasers, radio frequency and intense pulsed light (IPL). Cosmeceuticals include skin care, eye care, skin lightening and scar care products.
The North American market accounts for about 45% of the global market. However, the dominance of the U.S. is shifting towards Asia, particularly in the energy- based devices segment. Asia is regarded as the next frontier and the number of physicians and clinics in China and India has been steadily rising, along with medical tourism in the region. In the injectables and devices category, the E.U. occupies the second position behind the U.S. Brazil continues to be a strong market for aesthetics and cosmetic procedures. The Russian market is also experiencing fast growth compared to many E.U. countries and the Russian market is particularly strong for devices and topicals.
Along with the global giants such as Allergan, Galderma and Merz, a lot of smaller players are offering wrinkle relaxing agents and wrinkle fillers. These products have only temporary effects requiring repeated procedures. The market for these products is nearing maturity and they are widely accepted only in the U.S. and E.U., whereas, permanent fillers are widely in demand in Asia. Artefill is considered to be a semi-permanent to permanent filler. It contains a synthetic ingredient known as polymethyl methacrylate (PMMA) mixed with animal collagen. Use of off-the-shelf dermal fillers and fillers containing lidocaine for pain management is becoming a gold standard in the E.U. and U.S. markets.
Another growth market is for body shaping procedures that involves reduction of fat, cellulite, skin laxity and vein removal. An injectable drug ATX-101 (deoxycholic acid), currently in clinical trials is most likely to become a game changer in body contouring segment in the near future. On July 10, 2014, the FDA accepted the filing of New Drug Application (NDA) for this drug by Kythera Biopharmaceuticals. Plug-in at-home devices for treating sun damage, hair removal, skin discoloration, acne, hair growth, skin texture, microdermabrasion and cellulite continue to expand particularly in developed markets. As a new innovation, the aesthetic market is expected to witness the launch of transepidermal drug delivery technologies for facilitating topical treatments.
On the other hand, trends in minimally invasive procedures are seen reflecting microeconomic indicators. Revenues from minimally invasive procedures increase along with home prices, disposable income per capita and real Gross Domestic Product per capita. Thus, in the recent past, there was a 200% increase in service revenues generated by minimally invasive cosmetic procedures such as botulinum toxin and dermal fillers.
Key Topics Covered:
1.1 Objectives of Report
1.2 Scope of the Study
1.3 Summary of the Report
1.4 Cosmetic Surgery Service Market
1.5 Cosmetic Surgery Products Market
2.0 Surgical Cosmetic Procedures: An Overview
2.1 Differences between Cosmetic Surgery and Reconstructive Surgery
2.2 Types of Surgical Cosmetic Procedures
2.3 Popular Cosmetic Surgeries in Selected Countries
3.0 Nonsurgical Cosmetic Procedures: An Overview
3.1 Botulinum Toxin Injection
3.2 Calcium Hydroxylapatite Injection
3.3 Hyaluronic Acid Injection
3.4 Poly-L-Lactic Acid Injection
3.5 Chemical Peel
3.7 Laser Skin Resurfacing
3.8 Laser Hair Removal
3.9 Popular Nonsurgical Cosmetic Surgical Procedures in the U.S.
3.10 Cosmetic Procedures in Germany
3.11 Cosmetic Surgery in U.K.
3.12 Cosmetic Procedures in France
3.13 Surgical Cosmetic Procedures in Ireland
3.14 Cosmetic Surgery in Singapore
3.15 Cosmetic Surgery in United Arab Emirates (UAE)
3.16 Cosmetic Surgery Prices in Cosmetic Tourism Destinations in Americas
3.17 Cosmetic Surgery Prices in Eastern Europe
3.18 Cosmetic Surgery Prices in Asia
4.0 Physician Dispensed Cosmeceuticals: An Overview
4.1 Physician-Dispensed Skincare Cosmecuticals
4.3 Photoaging of Skin
4.4 Cosmeceuticals for the Treatment of Acne
4.5 Physician-Dispensed Eyelash Products
4.6 Skin Lightening Cosmeceuticals
4.7 Scar Care Cosmeceuticals
4.9 DNA Tests for Skincare
4.10 Stem Cells in Skin Care Products
4.11 Cosmeceuticals: Major Companies and Product Lines
5.0 Cosmetic Surgery Products and Technologies: An Overview
5.1 Breast Implants
5.2 Gluteal Implants
5.3 Facial Implants
5.4 Injectable Neuromodulators
5.6 Dermal Fillers
6.0 Energy-Based Technologies for Cosmetic Procedures: An Overview
6.1 Types of Energy-Based Technologies
6.2 Major Applications of Energy-Based Devices
6.3 Brief Description of Selected Laser Technologies
6.4 Currently Available Fractional Laser Systems
6.5 Currently Available Body Shaping Systems
6.6 Skin Rejuvenation Technologies
6.7 Hair Removal Technologies
6.8 Technologies for Vascular Indications
6.9 Laser/Light Technologies for Acne Treatment
7.0 Emerging Technologies in the Aesthetic Sector
7.1 Brief Description of Emerging Technologies
8.0 Current Clinical Trials for Aging Skin
8.1 NCT Number: NCT01529788
8.2 NCT Number: NCT01212809
8.3 NCT Number: NCT02003833
8.4 NCT Number: NCT00761878
8.5 NCT Number: NCT00272610
8.6 NCT Number: NCT00352157
8.7 NCT Number: NCT01447342
8.8 NCT Number: NCT00541931
8.9 NCT Number: NCT01451476
8.10 NCT Number: NCT00818311
8.11 NCT Number: NCT00856414
8.12 NCT Number: NCT01379365
8.13 NCT Number: NCT00121511
8.14 NCT Number: NCT01940991
8.15 NCT Number: NCT01783496
8.16 NCT Number: NCT01776606
8.17 NCT Number: NCT00956020
8.18 NCT Number: NCT00355823
8.19 NCT Number: NCT01910831
9.0 Market Analysis & Forecast Through 2022
9.1 Recent Market Trends
9.2 Cosmetic Surgery Market by Segment
9.3 Global Cosmetic Surgery Market by Product Segments
10.0 Company Profiles
10.1 Aerolase Corp.
10.2 Adoderm GmbH
10.3 Aesthetic Dermal S.L.
10.4 Allergan Inc.
10.5 Allied Biomedical
10.6 Alma Lasers Ltd. (Fosun Pharma)
10.7 Andrew Technologies LLC
10.8 Anika Therapeutics
10.9 Anteis S.A.
10.10 Apira Science Inc.
10.11 Aqtis Medical BV
10.12 Arion Laboratoires
10.13 Baby Quasar
10.14 BENEV Company Inc.
10.15 Biopelle Inc.
10.16 Biotechnique Avance
10.17 Breit Aesthetics Ltd.
10.18 BTL Industries Inc.
10.19 Carol Cole Co.
10.21 Chromogenex PLC
10.22 Classys Inc.
10.23 Caontura International A/S
10.24 CoolTouch Inc.
10.25 Cutera Inc.
10.26 Cynosure Inc.
10.27 Deka Laser Technologies Inc.
10.28 DermaMed Solutions LLC
10.29 Eclipse Aesthetics LLC
10.30 Edge Systems LLC
10.31 Ellipse A/S
10.32 Ellman International Inc.
10.33 Energist Medical Group
10.34 Envy Medical Inc.
10.35 Erchonia Corp.
10.36 Establishment Labs
10.37 EunSung Global Corp.
10.38 Eurosilicone S.A.S.
10.39 Focus Medical
10.40 Fotona D.D.
10.41 Galderma S.A.
10.42 General Project S.R.L.
10.43 Groupe Sebbin SA
10.44 GS Aesthetics PLC
10.45 Guangzhou Wanhe Plastic Materials Co., Ltd.
10.46 Hironic Co., Ltd.
10.47 Home Skinovations Ltd.
10.48 Human Med AG
10.49 Iluminage Beauty Inc.
10.50 Invasix Ltd.
10.51 Ispen Biopharmaceuticals Inc.
10.52 Jeisys Medical Inc.
10.53 JeNu Biosciences Inc.
10.54 Laboratoires Filorga SA
10.55 Lasering S.R.L.
10.56 Laxington International LLC
10.57 L' Oreal International
10.58 LSO Medical Groupe
10.59 Lumenis Ltd.
10.60 Lumiere Medical
10.61 Lutronic Corp.
10.62 Medy-Tox Inc.
10.64 Mentor Worldwide LLC
10.65 Merz Aesthetics Inc.
10.66 Myoscience Inc.
10.67 Nagor Ltd.
10.68 Novoxel Ltd.
10.69 Obagi Medical Products Inc.
10.70 Pantec Biosolutions AG
10.71 PCA Skin
10.72 PhotoMedex Inc.
10.73 Phytoceuticals Inc.
10.74 Polytech Health & Aesthetics GmbH
10.75 Pollogen Ltd.
10.76 Prollenium Medical Technologies Inc.
10.77 Protocadmus Technologies Spain S.L.
10.78 Quanta System S.P.A.
10.79 Radiancy Inc.
10.80 Restoration Robotics Inc.
10.81 Rhonda Allison Clinical Enterprises
10.82 Sciton Inc.
10.83 Scientra Inc.
10.84 SharpLight Technologies Ltd.
10.85 Skinceuticals Inc.
10.87 Solta Medical Inc.
10.88 Spectrum Brands Inc. (Remington)
10.89 Suneva Medical Inc.
10.90 Super Grow Lasers Inc.
10.91 Surgiform Technology Ltd.
10.92 Surgisil LLC
10.93 Sybaritic Inc.
10.94 Syneron Medical Ltd.
10.95 Tavger Ltd.
10.96 TavTech Ltd.
10.97 Teoxane Laboratories
10.98 The Dezac Group Ltd.
10.99 Tria Beauty Inc.
10.100 Venus Concept Ltd.
10.101 Viora Inc.
10.102 Won Tech Co., Ltd.
10.103 YA-MAN Ltd.
10.104 Zeltiq Aesthetics Inc.
11.0 Medical Aesthetic Industry Participants & Participating Segments
For more information about this report visit https://www.researchandmarkets.com/research/vhhpg8/global_5?w=5
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets